892 filings
Page 2 of 45
424B4
APTO
Aptose Biosciences Inc
26 Jan 24
Prospectus supplement with pricing info
5:30pm
8-K
APTO
Aptose Biosciences Inc
26 Jan 24
Aptose Announces Pricing of $8.4 Million Public Offering and a Concurrent $4 Million Private Placement with Hanmi Pharmaceutical
8:00am
EFFECT
APTO
Aptose Biosciences Inc
26 Jan 24
Notice of effectiveness
12:15am
S-1MEF
APTO
Aptose Biosciences Inc
25 Jan 24
Registration of additional securities for an S-1
9:44pm
CORRESP
APTO
Aptose Biosciences Inc
24 Jan 24
Correspondence with SEC
12:00am
CORRESP
APTO
Aptose Biosciences Inc
24 Jan 24
Correspondence with SEC
12:00am
S-1/A
APTO
Aptose Biosciences Inc
IPO registration (amended)
19 Jan 24
9:50pm
S-1/A
APTO
Aptose Biosciences Inc
IPO registration (amended)
29 Dec 23
4:10pm
8-K
APTO
Aptose Biosciences Inc
11 Dec 23
Aptose Tuspetinib Clinical Data Featured in Oral Presentation at the 2023 ASH Annual Meeting
6:30am
S-1/A
APTO
Aptose Biosciences Inc
IPO registration (amended)
11 Dec 23
6:15am
UPLOAD
APTO
Aptose Biosciences Inc
5 Dec 23
Letter from SEC
12:00am
S-1
APTO
Aptose Biosciences Inc
IPO registration
1 Dec 23
8:29pm
8-K
APTO
Aptose Biosciences Inc
30 Nov 23
Aptose Appoints Fletcher Payne Chief Business Officer, Expanding his Executive Role
5:28pm
10-Q
2023 Q3
APTO
Aptose Biosciences Inc
Quarterly report
9 Nov 23
5:00pm
8-K
APTO
Aptose Biosciences Inc
9 Nov 23
Aptose Reports Results for the Third Quarter 2023
4:15pm
8-K
APTO
Aptose Biosciences Inc
2 Nov 23
Aptose Tuspetinib Clinical Data Selected for Oral Presentation at the 2023 ASH Annual Meeting
9:15am
8-K
APTO
Aptose Biosciences Inc
30 Oct 23
Aptose Presents Highlights from Clinical Update Webcast Featuring Latest Available Data on AML Drug Tuspetinib
9:20am
8-K
APTO
Aptose Biosciences Inc
26 Oct 23
Regulation FD Disclosure
10:12am
8-K
APTO
Aptose Biosciences Inc
23 Oct 23
Aptose to Hold Clinical Update and KOL Data Review of AML Drug Tuspetinib on Monday, October 30th
8:00am
8-K
APTO
Aptose Biosciences Inc
16 Oct 23
Aptose Clinical and Preclinical Data to be Presented at European School of Haematology (ESH) 6th International Conference
8:00am